Andrew Allen

Andrew Allen

Company: Gritstone bio

Job title: CEO


Considerations for the Development of Personalised Neoantigen-Based Cancer Vaccines 8:30 am

• Reviewing updates on current individualised cancer vaccine clinical approaches, successes, and challenges • Considering factors for process design and specifications for a personalised neoantigen-based vaccine and a customised neoantigen based cell therapy • Exploring approaches for dealing with human and process variabilityRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.